JP2023518064A5 - - Google Patents

Info

Publication number
JP2023518064A5
JP2023518064A5 JP2022555990A JP2022555990A JP2023518064A5 JP 2023518064 A5 JP2023518064 A5 JP 2023518064A5 JP 2022555990 A JP2022555990 A JP 2022555990A JP 2022555990 A JP2022555990 A JP 2022555990A JP 2023518064 A5 JP2023518064 A5 JP 2023518064A5
Authority
JP
Japan
Prior art keywords
weight
composition
ginsenosides
total ginsenosides
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022555990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518064A (ja
JP7808042B2 (ja
Filing date
Publication date
Priority claimed from GBGB2004121.6A external-priority patent/GB202004121D0/en
Priority claimed from GBGB2005288.2A external-priority patent/GB202005288D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/056803 external-priority patent/WO2021185897A1/en
Publication of JP2023518064A publication Critical patent/JP2023518064A/ja
Publication of JP2023518064A5 publication Critical patent/JP2023518064A5/ja
Application granted granted Critical
Publication of JP7808042B2 publication Critical patent/JP7808042B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022555990A 2020-03-20 2021-03-17 ギンセノシド組成物 Active JP7808042B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2004121.6A GB202004121D0 (en) 2020-03-20 2020-03-20 Improved compositions
GB2004121.6 2020-03-20
GB2005288.2 2020-04-09
GBGB2005288.2A GB202005288D0 (en) 2020-04-09 2020-04-09 Improved compositions
PCT/EP2021/056803 WO2021185897A1 (en) 2020-03-20 2021-03-17 Ginsenoside compositions

Publications (3)

Publication Number Publication Date
JP2023518064A JP2023518064A (ja) 2023-04-27
JP2023518064A5 true JP2023518064A5 (cg-RX-API-DMAC7.html) 2024-03-29
JP7808042B2 JP7808042B2 (ja) 2026-01-28

Family

ID=75108332

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022555990A Active JP7808042B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物
JP2022556000A Active JP7850670B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022556000A Active JP7850670B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Country Status (8)

Country Link
US (2) US20230124503A1 (cg-RX-API-DMAC7.html)
EP (2) EP4121061A1 (cg-RX-API-DMAC7.html)
JP (2) JP7808042B2 (cg-RX-API-DMAC7.html)
CN (2) CN115315264A (cg-RX-API-DMAC7.html)
AU (2) AU2021238639B2 (cg-RX-API-DMAC7.html)
BR (2) BR112022015826A2 (cg-RX-API-DMAC7.html)
CA (2) CA3174699A1 (cg-RX-API-DMAC7.html)
WO (2) WO2021185897A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230124503A1 (en) * 2020-03-20 2023-04-20 Givaudan Sa Ginsenoside compositions
JP2023161983A (ja) * 2022-04-26 2023-11-08 石川県公立大学法人 サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物
CN117224553B (zh) * 2023-11-02 2025-08-12 浙江大学 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用
CN117752706B (zh) * 2023-12-20 2025-10-14 浙江天皇药业有限公司 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用
WO2025261873A1 (en) 2024-06-20 2025-12-26 Givaudan Sa Improvements in or relating to compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) * 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
KR102200012B1 (ko) * 2013-04-02 2021-01-08 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 뇌 활성화 조성물
US10456436B2 (en) * 2013-11-04 2019-10-29 Wen Luan Wendy Hsiao Use of herbal saponins to regulate gut microflora
BR112020000963A2 (pt) 2017-07-18 2020-07-14 Senescence Life Sciences Pte. Ltd. composições e métodos para o tratamento e prevenção de declínio cognitivo e conservação da função neuronal
CN110613802A (zh) * 2018-06-20 2019-12-27 珠海岐微生物科技有限公司 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途
CN109432304A (zh) * 2018-12-03 2019-03-08 杭州胡庆余堂药业有限公司 一种含铁皮石斛组合物在药物制备中的应用
US20230124503A1 (en) 2020-03-20 2023-04-20 Givaudan Sa Ginsenoside compositions

Similar Documents

Publication Publication Date Title
US20230022324A1 (en) Compositions and methods to regulate hormonal cascades in stress disorders
JP2023519189A5 (cg-RX-API-DMAC7.html)
Yampolsky et al. Sea buckthorn (lat. Hippophaë)
CN105287614B (zh) 一种灯银脑通药物组合物及其制备方法、制剂与应用
Dayanarayana et al. Non surgical approaches in treatment of OSF
AU2021258478A1 (en) Composition comprising fibre and mulberry
Shahrajabian et al. A review of three ancient Chinese herbs, goji berry, ginger and ginseng in pharmacological and modern science
CN120456901A (zh) 生物活性组合物及其使用方法
CN105050607B (zh) 用于治疗关节炎和骨关节炎的方法和组合物
KR20240017012A (ko) 태반 조성물
CN103316144A (zh) 一种补益气血、养阴益阳、提高免疫力、抗疲劳、抑制血栓形成的中药组合物
CN109954052A (zh) 一种具有抗氧化活性的组合物
CN104127703B (zh) 一种用于治疗口眼歪斜、面痉、面部挛痛的中药组合物及其制备方法
US11484562B2 (en) Composition for preventing or treating obesity comprising natural mixture extracts
CN101254243B (zh) 治疗乳腺增生的外敷散
CN101797371B (zh) 一种用于减肥按摩的药物组合物
CN106139041A (zh) 一种治疗乳腺增生的配方中药
CN1586578A (zh) 养胃强脾丸
CN101147585A (zh) 一种适用于乳腺增生妇女的功能食品
Kim A Case Report on the Improvement of Hyperhidrosis and Diarrhea through Ortho-Cellular Nutrition Therapy (OCNT)
ITUB20154160A1 (it) Composizione nutraceutica per il dimagrimento a base di componenti di origine naturale.
CN104435841A (zh) 一种用于治疗缺血性心脏病的中药制剂及其制备方法
CN103638343B (zh) 防治慢性腹泻的药物的制备方法
CN103505484A (zh) 一种沙棘总黄酮亚油酸中药组合物及制备方法
CN108837124A (zh) 一种治疗胆结石的中药